查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1886472

热原检测市场－全球产业规模、份额、趋势、机会和预测，按检测类型、最终用户、地区和竞争格局划分，2020-2030年预测

Pyrogen Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Test Type, By End User, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 184 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024年全球热原检测市场规模为15.5亿美元，预计2030年将以9.60%的复合年增长率成长至26.9亿美元。热原检测是一项关键的品质控制流程，旨在检测和量化药品、医疗器材和其他无菌材料中的热原（致热物质），从而确保患者免受发热反应的侵害。全球热原检测市场的成长主要受製药和生物技术研发活动日益增长的推动，同时全球卫生监管机构也提出了严格的监管要求，这些要求对产品安全和品质保证提出了更高的要求。

市场概览
预测期 2026-2030
市场规模：2024年 15.5亿美元
市场规模：2030年 26.9亿美元
复合年增长率：2025-2030年 9.60%
成长最快的细分市场 LAL 试验
最大的市场 北美洲

主要市场驱动因素

製药和生物技术产业的扩张是全球热原检测市场的主要驱动力，因为新药研发，特别是生物製剂和先进疗法的研发，都需要全面的品质控制。这些产业的强劲成长直接转化为对热原检测日益增长的需求，以确保整个生产过程中的产品安全。

主要市场挑战

先进的热原检测设备和试剂的高昂成本严重阻碍了全球热原检测市场的成长。这一经济障碍限制了必要检测能力的普及，尤其对于规模较小的企业和资源有限的环境而言更是如此。

主要市场趋势

受伦理考量、科学认知提升和监管环境变化的影响，全球市场正经历着向体外热原检测方法的显着转变。这些无需动物实验的替代方法，例如单核细胞活化试验 (MAT) 和重组因子 C (rFC) 检测，具有更高的重复性和可靠性，并且能够同时检测内毒素和非内毒素热原。

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球热原检测市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依检测类型（LAL 试验、兔热原试验、单核细胞活化试验、其他）
    • 依最终用户分类（製药和生技公司、医疗器材公司、其他）
    • 按地区
    • 按公司（2024 年）
  • 市场地图

第六章：北美热原检测市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第七章：欧洲热原检测市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国家分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区热原检测市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲热原检测市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东和非洲：国家分析
    • 沙乌地阿拉伯
    • 阿联酋
    • 南非

第十章：南美洲热原检测市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国家分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章：市场动态

  • 司机
  • 挑战

第十二章：市场趋势与发展

  • 併购
  • 产品发布
  • 最新进展

第十三章：全球热原侦测市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商议价能力
  • 顾客的力量
  • 替代产品的威胁

第十五章：竞争格局

  • Merck KGaA
  • Genscript Corporation
  • Lonza Group AG
  • bioMerieux SA
  • Novo Holdings A/S
  • Eurofins Scientific SE
  • Charles River Laboratories International, Inc.
  • WuXi AppTec Co., Ltd.

第十六章：策略建议

第17章调查会社について・免责事项

简介目录
Product Code: 23540

The Global Pyrogen Testing Market, valued at USD 1.55 Billion in 2024, is projected to experience a CAGR of 9.60% to reach USD 2.69 Billion by 2030. Pyrogen testing is a critical quality control process designed to detect and quantify pyrogens, fever-inducing substances, in pharmaceutical products, medical devices, and other sterile materials, thereby ensuring patient safety against febrile reactions. The global pyrogen testing market's growth is primarily driven by the increasing volume of pharmaceutical and biotechnology research and development activities, coupled with stringent regulatory mandates from health authorities worldwide that necessitate rigorous product safety and quality assurance.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1.55 Billion
Market Size 2030USD 2.69 Billion
CAGR 2025-20309.60%
Fastest Growing SegmentLAL Tests
Largest MarketNorth America

Key Market Drivers

The expansion of the pharmaceutical and biotechnology industries constitutes a primary driver for the global pyrogen testing market, as the increasing volume of new drug development, particularly biologics and advanced therapies, necessitates comprehensive quality control. The robust growth in these sectors directly translates into a heightened demand for pyrogen detection to ensure product safety throughout the manufacturing process.

Key Market Challenges

The high cost associated with advanced pyrogen testing equipment and reagents significantly impedes the growth of the global pyrogen testing market. This financial barrier limits the adoption of necessary testing capabilities, particularly for smaller entities and in environments with constrained resources. Implementing sophisticated pyrogen testing methodologies requires substantial initial capital investment for purchasing specialized instruments and ongoing expenditure for consumables, maintenance, and skilled personnel training. Such costs can be prohibitive for small to medium-sized enterprises, which often operate with tighter budgets and fewer financial reserves compared to larger pharmaceutical corporations.

Key Market Trends

The global market is experiencing a notable shift towards in vitro pyrogen testing methods, driven by ethical considerations, increased scientific understanding, and evolving regulatory landscapes. These animal-free alternatives, such as the Monocyte Activation Test (MAT) and recombinant Factor C (rFC) assays, provide enhanced reproducibility, reliability, and the capacity to detect both endotoxin and non-endotoxin pyrogens. The adoption of these methods has been strongly supported by regulatory bodies.

Key Market Players

  • Merck KGaA
  • Genscript Corporation
  • Lonza Group AG
  • bioMerieux SA
  • Novo Holdings A/S
  • Eurofins Scientific SE
  • Charles River Laboratories International, Inc.
  • WuXi AppTec Co., Ltd.

Report Scope:

In this report, the Global Pyrogen Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pyrogen Testing Market, By Test Type:

  • LAL Tests
  • Rabbit Pyrogen Test
  • Monocyte Activation Test
  • Others

Pyrogen Testing Market, By End User:

  • Pharmaceutical and Biotechnology Companies
  • Medical Device Companies
  • Others

Pyrogen Testing Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Pyrogen Testing Market.

Available Customizations:

Global Pyrogen Testing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pyrogen Testing Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Test Type (LAL Tests, Rabbit Pyrogen Test, Monocyte Activation Test, Others)
    • 5.2.2. By End User (Pharmaceutical and Biotechnology Companies, Medical Device Companies, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Pyrogen Testing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Test Type
    • 6.2.2. By End User
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Pyrogen Testing Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Test Type
        • 6.3.1.2.2. By End User
    • 6.3.2. Canada Pyrogen Testing Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Test Type
        • 6.3.2.2.2. By End User
    • 6.3.3. Mexico Pyrogen Testing Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Test Type
        • 6.3.3.2.2. By End User

7. Europe Pyrogen Testing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Test Type
    • 7.2.2. By End User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Pyrogen Testing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Test Type
        • 7.3.1.2.2. By End User
    • 7.3.2. France Pyrogen Testing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Test Type
        • 7.3.2.2.2. By End User
    • 7.3.3. United Kingdom Pyrogen Testing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Test Type
        • 7.3.3.2.2. By End User
    • 7.3.4. Italy Pyrogen Testing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Test Type
        • 7.3.4.2.2. By End User
    • 7.3.5. Spain Pyrogen Testing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Test Type
        • 7.3.5.2.2. By End User

8. Asia Pacific Pyrogen Testing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Test Type
    • 8.2.2. By End User
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Pyrogen Testing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Test Type
        • 8.3.1.2.2. By End User
    • 8.3.2. India Pyrogen Testing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Test Type
        • 8.3.2.2.2. By End User
    • 8.3.3. Japan Pyrogen Testing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Test Type
        • 8.3.3.2.2. By End User
    • 8.3.4. South Korea Pyrogen Testing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Test Type
        • 8.3.4.2.2. By End User
    • 8.3.5. Australia Pyrogen Testing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Test Type
        • 8.3.5.2.2. By End User

9. Middle East & Africa Pyrogen Testing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Test Type
    • 9.2.2. By End User
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Pyrogen Testing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Test Type
        • 9.3.1.2.2. By End User
    • 9.3.2. UAE Pyrogen Testing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Test Type
        • 9.3.2.2.2. By End User
    • 9.3.3. South Africa Pyrogen Testing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Test Type
        • 9.3.3.2.2. By End User

10. South America Pyrogen Testing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Test Type
    • 10.2.2. By End User
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Pyrogen Testing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Test Type
        • 10.3.1.2.2. By End User
    • 10.3.2. Colombia Pyrogen Testing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Test Type
        • 10.3.2.2.2. By End User
    • 10.3.3. Argentina Pyrogen Testing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Test Type
        • 10.3.3.2.2. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Pyrogen Testing Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Merck KGaA
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Genscript Corporation
  • 15.3. Lonza Group AG
  • 15.4. bioMerieux SA
  • 15.5. Novo Holdings A/S
  • 15.6. Eurofins Scientific SE
  • 15.7. Charles River Laboratories International, Inc.
  • 15.8. WuXi AppTec Co., Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer